Patients' acceptance of antihypertensive therapy to prevent cardiovascular disease: A comparison between South Asians and Caucasians in the United Kingdom

European Journal of Preventive Cardiology

Volumn 15, Issue 1, 2008, Pages 59-66

  Aarabi, Mohsen ^a   Skinner, John ^b   Price, Charles E ^b   Jackson, Peter R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Sheffield West Primary Care Trust   (United Kingdom)

Author keywords

ethnicity; hypertension; minimal clinically important differences; patients' acceptance; South Asian

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; RANK SUM TEST; UNITED KINGDOM;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ASIA, SOUTHEASTERN; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GREAT BRITAIN; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PRIMARY PREVENTION; QUESTIONNAIRES;

EID: 39349107894     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3282f07973     Document Type: Article

References (35)

1. Haynes RB, Devereaux PJ, Guyatt GH. Clinical expertise in the era of evidence-based medicine and patient choice. ACP J Club 2002; 136: A11–A14.
2. Royal Pharmaceutical Society of Great Britain Working Party. From compliance to concordance: achieving shared goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain, Merck, Sharp and Dohme; 1997.
3. Devereaux PJ, Anderson DR, Gardner MJ, Putnam W, Flowerdew GJ, Brownell BF, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ 2001; 323: 1218–1222.
4. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997; 44: 681–692.
5. HPS. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7–22.
6. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121 (1 Pt 2):293–298.
7. JBS-2. Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91 (Suppl 5):v1–v52.
8. Department of Health. National Service Frameworks for coronary heart disease. London: Stationery Office; 2000.
9. Patel MG, Wright DJ, Gill PS, Jerwood D, Silcock J, Chrystyn H. Prescribing of lipid lowering drugs to South Asian patients: ecological study. BMJ 2002; 325: 25–26.
10. Bowling A, Ebrahim S. Measuring patients' preferences for treatment and perceptions of risk. Qual Health Care 2001; 10 (Suppl 1):i2–i8.
11. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407–415.
12. Lewis DK, Barton S. Who decides when to start preventive treatment? A questionnaire survey to compare the views of different population subgroups. J Epidemiol Community Health 2003; 57: 241–242.
13. McAlister FA, O'Connor AM, Wells G, Grover SA, Laupacis A. When should hypertension be treated? The different perspectives of Canadian family physicians and patients. CMAJ 2000; 163: 403–408.
14. Steel N. Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey. BMJ 2000; 320: 1446–1447.
15. Montgomery AA, Harding J, Fahey T. Shared decision making in hypertension: the impact of patient preferences on treatment choice. Fam Pract 2001; 18: 309–313.
16. Protheroe J, Fahey T, Montgomery AA, Peters TJ. The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. BMJ 2000; 320: 1380–1384.
17. Lip GY, Kamath S, Jafri M, Mohammed A, Bareford D. Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project. Stroke 2002; 33: 238–242.
18. Coy C, Skinner J, Stead M, Reid G. Sheffield: a picture of health? Report of the second Sheffield Health and Illness Prevalence Survey. Sheffield: Sheffield Health Authority and Sheffield Primary Care Trusts Informatics Services; 2002.
19. Nam Pehcham computer software (Version 1.1). Bradford: Bradford Health Authority, New Mill, Victoria Road, Saltaire, Shipley BD18 3LD. Computer Services, City of Bradford Metropolitan Council (Dept. 13), Britannia House, Bradford D1 1HX.
20. Elting LS, Martin CG, Cantor SB, Rubenstein EB. Influence of data display formats on physician investigators' decisions to stop clinical trials: prospective trial with repeated measures. BMJ 1999; 318: 1527–1531.
21. Gigerenzer G. The psychology of good judgment: frequency formats and simple algorithms. Med Decis Making 1996; 16: 273–280.
22. Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med 1997; 127: 966–972.
23. Price C, Skinner J. The Sheffield Health and Exercise Survey. Sheffield: Sheffield Primary Care Trusts; 2003.
24. Carstairs V, Morris R. Deprivation and Health in Scotland. Aberdeen: Aberdeen University Press; 1991.
25. Trewby PN, Reddy AV, Trewby CS, Ashton VJ, Brennan G, Inglis J. Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs. Clin Med 2002; 2: 527–533.
26. Man-Son-Hing M, Laupacis A, O'Connor A, Wells G, Lemelin J, Wood W, et al. Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med 1996; 156: 1841–1848.
27. France MW, Kwok S, McElduff P, Seneviratne CJ. Ethnic trends in lipid tests in general practice. QJM 2003; 96: 919–923.
28. Mukhopadhyay B, Forouhi NG, Fisher BM, Kesson CM, Sattar N. A comparison of glycaemic and metabolic control over time among South Asian and European patients with Type 2 diabetes: results from follow-up in a routine diabetes clinic. Diabet Med 2006; 23: 94–98.
29. McElduff P, Edwards R, Burns JA, Young RJ, Heller R, Long B, et al. Comparison of processes and intermediate outcomes between South Asian and European patients with diabetes in Blackburn, north-west England. Diabet Med 2005; 22: 1226–1233.
30. Reed WW, Herbers JE Jr, Noel GL. Cholesterol-lowering therapy: what patients expect in return. J Gen Intern Med 1993; 8: 591–596.
31. Sweeney K, Heath I. A taxonomy of general practice. Br J Gen Pract 2006; 56: 386–388.
32. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634–640.
33. Llewellyn-Thomas HA. Investigating patients' preferences for different treatment options. Can J Nurs Res 1997; 29: 45–64.
34. Voller H, Dovifat C, Glatz J, Kortke H, Taborski U, Wegscheider K. Self management of oral anticoagulation with the IN ratio system: impact of a structured teaching program on patient's knowledge of medical background and procedures. Eur J Cardiovasc Prev Rehabil 2004; 11: 442–447.
35. Misselbrook D, Armstrong D. Patients' responses to risk information about the benefits of treating hypertension. Br J Gen Pract 2001; 51: 276–279.